Uterine cancer rates rising, particularly among black women
Uterine cancer is on the rise in the U.S. and it's killing black women at a higher rate than any other group, a report says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 7, 2018 Category: Consumer Health News Source Type: news

Uterine Cancer Incidence and Deaths on the Rise in US Uterine Cancer Incidence and Deaths on the Rise in US
Black women in particular need to be more aware of the symptoms of uterine cancer to stem the rise in the incidence and mortality rates of uterine cancer in the US, warn CDC experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 7, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Obesity May Be Driving Rise in Uterine Cancers
Title: Obesity May Be Driving Rise in Uterine CancersCategory: Health NewsCreated: 12/6/2018 12:00:00 AMLast Editorial Review: 12/7/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 7, 2018 Category: Cancer & Oncology Source Type: news

Since 1999, Uterine Cancer Incidence, Mortality Up
Incidence of uterine cancer higher among non - Hispanic black and white women; more deaths for blacks (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 7, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Journal, Source Type: news

Obesity May Be Driving Rise in Uterine Cancers
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 6, 2018 Category: Cancer & Oncology Tags: Oncology, Nutrition, News, Source Type: news

Since 1999, Uterine Cancer Incidence, Mortality Up
THURSDAY, Dec. 6, 2018 -- The incidence of uterine cancer and uterine cancer deaths has increased since 1999, according to research published in the Dec. 7 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 6, 2018 Category: Pharmaceuticals Source Type: news

Obesity May Be Driving Rise in Uterine Cancers
THURSDAY, Dec. 6, 2018 -- Cases of uterine cancer are charting a slow but steady rise among American women, and so are deaths from the disease, new statistics show. Looking at federal health data, researchers from the U.S. Centers for Disease... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 6, 2018 Category: General Medicine Source Type: news

Obesity May Be Driving Rise in Uterine Cancers
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

The First Baby Has Been Born After a Uterus Transplant From a Deceased Donor
The world’s first baby born by a uterus transplant from a deceased donor is healthy and nearing her first birthday, according to a new case study published Tuesday in the Lancet. Uterus transplants have become more common in recent years, resulting in 11 live births around the world. But all of the other successful deliveries so far have been made possible by living donors — often women who opt to donate their uterus to a close friend or family member without one. The birth resulting from the case detailed in the Lancet, which took place at Brazil’s Hospital das Clínicas last December, is both the first...
Source: TIME: Health - December 4, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized fertility healthytime Source Type: news

Scientists identify new genetic causes linked to abnormal pregnancies and miscarriages
(McGill University Health Centre) A team of scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University have identified three genes responsible for recurrent molar pregnancies, a rare complication that occurs when a non-viable pregnancy with no embryo implants in the uterus. The results of this study, published in The American Journal of Human Genetics, could have important implications, since until now very little is known about the genetic causes of all forms of fetal loss. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 20, 2018 Category: Cancer & Oncology Source Type: news

Artificial intelligence for MRI distinguishes uterine cancer from fibroids
A machine-learning algorithm for MRI helped clinicians differentiate uterine...Read more on AuntMinnie.comRelated Reading: Study finds low reintervention rate for UAE of fibroids MRgFUS offers less-invasive fibroid fix Further intervention rates vary after fibroid removal Online patient info about UAE could be better MRI helps distinguish fibroids from uterine cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 15, 2018 Category: Radiology Source Type: news

More Data Tie Obesity to Occult Endometrial Cancer
(MedPage Today) -- Bariatric surgery appeared to normalize neoplastic endometrium in some women (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 1, 2018 Category: Endocrinology Source Type: news

New study takes first step toward treating endometriosis
(Northwestern University) Researchers at Northwestern Medicine have taken the first step in bioengineering the human uterus to treat endometriosis, uterine-factor infertility and endometrial cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 1, 2018 Category: Cancer & Oncology Source Type: news

Minimally invasive surgery for cervical cancer is MORE dangerous than open operations, study finds
Less invasive surgery to remove the cervix and uterus of early stage cervical cancer patients raises the risk of death later by 65%, a Massachusetts General Hospital study found. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2018 Category: Consumer Health News Source Type: news

Minimally Invasive Surgery Is Standard for Cervical Cancer. But A New Study Shows It ’s Not Effective
In a demonstration that newer isn’t always better, two studies published in the New England Journal of Medicine show that minimally invasive surgery techniques, including robotic surgery, lead to higher death rates from any cause than traditional, open surgery done through an incision in the abdomen. Minimally invasive surgery — or keyhole surgery, in which doctors perform operations through small incisions rather than by opening up patients and exposing them to complications — and robotic surgery have shortened recovery times and cut back on infections and bleeding. So in many cases, surgeons prefer usin...
Source: TIME: Health - October 31, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news

Studies Warn Against Minimally Invasive Surgery for Cervical Cancer
Compared to open surgery for cervical cancer, the less invasive approach was more likely to result in cancer recurrence and death, new studies found. (Source: NYT Health)
Source: NYT Health - October 31, 2018 Category: Consumer Health News Authors: DENISE GRADY Tags: Cervical Cancer Uterine Cancer Surgery and Surgeons Human Papillomavirus (HPV) Cervix Uterus Tumors Fibroids Hysterectomies Food and Drug Administration New England Journal of Medicine Pedro T. Ramirez Johns Hopkins University Me Source Type: news

Mother lost over half her body weight after medics blamed her cervical cancer on her obese frame
Rebecca Lane, now 39, from Sherborne, Dorset, weighed 18st 5lbs (116.5kg) when she was diagnosed in July 2016. She was forced to have her uterus and cervix removed. (Source: the Mail online | Health)
Source: the Mail online | Health - October 23, 2018 Category: Consumer Health News Source Type: news

Tainted Valsartan Not Linked to Cancer Risk in the Short Term Tainted Valsartan Not Linked to Cancer Risk in the Short Term
An expedited short-term analysis finds no increased risk for cancer in patients who took NDMA-contaminated valsartan, but uncertainty remains for colorectal and uterine cancer. The EMA weighs in.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 13, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Doctor to the stars disciplined over use of controversial menopause therapy
This story is from Kaiser Health News. A Santa Monica doctor who touted a controversial menopause therapy on the Oprah Winfrey Network and received testimonials for her work from such celebrity patients as model Cindy Crawford and actress-author Suzanne Somers has been disciplined by California’s medical board for gross negligence. In a settlement approved late last month, the Medical Board of California put Dr. Prudence Hall on probation for four years, faulting her for being “unaware” of potential risks posed by the plant-based hormones — including cancer —&nbs...
Source: ABC News: Health - September 12, 2018 Category: Consumer Health News Tags: Health Source Type: news

Green Dye Beats Blue for Node Mapping in Uterine Cancer Green Dye Beats Blue for Node Mapping in Uterine Cancer
Green fluorescent dye was found to be superior to standard blue dye for sentinel lymph node mapping in uterine cancers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 5, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Sentinel Lymph Node Mapping Most Cost - Effective for Uterine CA
Findings compared to routine, selective lymphadenectomy for low - risk endometrial cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 21, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Radiology, Surgery, Journal, Source Type: news

Medical News Today: What can cause cramps after menopause?
Although a person's monthly periods stop after they have been through menopause, they may still sometimes experience abdominal cramping. These cramps are usually nothing serious, but can sometimes be a sign of an underlying medical condition, such as uterine fibroids, endometriosis, or cancer. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 13, 2018 Category: Consumer Health News Tags: Menopause Source Type: news

Inside Hologic ’ s evolving definition of women ’ s healthcare
Hologic (NSDQ:HOLX), known in the medtech industry for its mammography and diagnostics devices, is rethinking what it means to be a women’s healthcare company. The 6,000-person company wants to expand its reach to include products that care for women’s well-being, as well as their health – a concept that Dr. Edward Evantash honed when he led the Ob/Gyn division at Tufts Medical Center. “The beauty of being an Ob/Gyn is that you really take care of women throughout the continuum of their lifecycle,” Evantash, Hologic’s medical director & VP of global medical affairs, told MassDev...
Source: Mass Device - August 13, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Food & Drug Administration (FDA) Women's Health Cynosure Inc. Hologic Source Type: news

Mayo Clinic Q and A: Uterine polyps rarely are cancerous
DEAR MAYO CLINIC: I have a few small uterine polyps that my health care provider says are not likely to be cancerous and that I could be reevaluated in six months to see if further testing is needed. Is it common for uterine polyps to turn into cancer? I am 49. ANSWER: It is rare [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 31, 2018 Category: Databases & Libraries Source Type: news

Bariatric surgery may reduce hormone-related cancer risk
New research published in theBritish Journal of Surgery reports that bariatric surgery is associated with a decreased risk of breast, endometrium, and prostate cancer.Medpage Today (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 25, 2018 Category: Endocrinology Source Type: news

Fertility treatment doesn't boost overall risk of breast, ovary or uterus cancers
(Reuters Health) - Assisted reproductive technologies don't carry an overall increased risk of breast, ovarian or uterine cancer, according to a new study in the UK. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Do fertility treatments bring higher risk of invasive breast or uterine cancer?
“What we were really interested in is for the ladies -- did they have long-term downstream effects in terms of risks of cancers?” said Alastair Sutcliffe. (Source: ABC News: Health)
Source: ABC News: Health - July 19, 2018 Category: Consumer Health News Tags: Health Source Type: news

Trastuzumab Increases PFS in Women With HER2/neu Uterine Cancer Trastuzumab Increases PFS in Women With HER2/neu Uterine Cancer
This well-done study should prompt oncologists to consider adding trastuzumab to carboplatin-paclitaxel treatment for women with advanced HER2/neu-positive uterine cancer, says Dr Maurie Markman.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 13, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Airline Crew Have Higher Cancer Rates
Flight attendants had increased rates of breast, uterine, cervical, gastrointestinal, skin and thyroid cancers. (Source: NYT Health)
Source: NYT Health - July 5, 2018 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Airlines and Airplanes Flight Attendants Radiation Cancer Biorhythms Source Type: news

Flight Attendants May Have Higher Cancer Rates Flight Attendants May Have Higher Cancer Rates
U.S. flight attendants may be more likely than other Americans to develop several types of cancer including tumors of the breast, uterus, cervix, thyroid and skin, new research suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 26, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Flight attendants get more uterine, thyroid and other cancers, study finds
(Source: CNN.com - Health)
Source: CNN.com - Health - June 26, 2018 Category: Consumer Health News Source Type: news

Flight attendants may have higher cancer rates
(Reuters Health) - U.S. flight attendants may be more likely than other Americans to develop several types of cancer including tumors of the breast, uterus, cervix, thyroid and skin, new research suggests. (Source: Reuters: Health)
Source: Reuters: Health - June 26, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Flight Attendants Have Higher Rates of Many Cancers, Study Says
Flight attendants are exposed to a number of known cancer-causing risks, but few studies have rigorously quantified that risk, and researchers say they are an understudied occupational group. The Harvard Flight Attendant Health Study (FAHS), begun in 2007, addresses some of the gaps in understanding health risks among flight attendants. In the latest report, published in the journal Environmental Health, researchers found that flight attendants had higher rates of many cancers, including breast cancer and melanoma, compared to the general population. The FAHS included more than 5,300 flight attendants who were recruited th...
Source: TIME: Health - June 26, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news

US flight attendants at elevated risk of several forms of cancer
(Harvard T.H. Chan School of Public Health) US flight attendants have a higher prevalence of several forms of cancer, including breast cancer, uterine cancer, gastrointestinal cancer, thyroid cancer, and cervical cancer, when compared with the general public, according to new research from Harvard T.H. Chan School of Public Health. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 25, 2018 Category: Cancer & Oncology Source Type: news

Power morcellation: Questions linger for controversial tech
Dr. Amy Reed’s tragic case brought to light the cancer risks posed by power morcellation. Her death hasn’t stopped lingering questions about the technology. Power morcellators were used for 20 years to laparoscopically remove fibroids, benign tumors of the uterus, raising not a single adverse event report with the FDA. That all changed in 2013, when Dr. Amy Reed, an attending physician at Beth Israel Deaconess Medical Center, underwent a myomectomy using power morcellation at nearby Brigham & Women’s Hospital. Reed’s fibroids were not benign, but instead a malignant form of cancer called uterine...
Source: Mass Device - June 1, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Gynecological Legal News News Well Recalls Regulatory/Compliance Surgical Cancer eximissurgical johnsonandjohnson powermorcellators Source Type: news

Obesity may make women more vulnerable to a host of cancers, especially if they gain weight quickly
Compared to women of normal weight, those with obesity are 24% more likely to develop one of a handful of cancers linked to the condition, and their chances of developing cancers of the kidney or endometrium were around twice as high as those of normal-weight women, new research has found.In a... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - May 23, 2018 Category: Science Authors: Melissa Healy Source Type: news

Study: Uterine cancer survivors have greater risk of cardiovascular problems
Survivors of uterine cancer are more likely to face cardiovascular problems several years after treatment, according to a study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 8, 2018 Category: Consumer Health News Source Type: news

Uterine cancer survivors are more likely to have cardiovascular problems
(Oxford University Press USA) A new study in the Journal of the National Cancer Institute indicates that survivors of uterine cancer are more likely to experience cardiovascular problems years after treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

UCLA research may explain some causes of infertility and miscarriage
A new study in the journal Nature Cell Biology has uncovered information about a key stage that human embryonic cells must pass through just before an embryo implants. The research, led by UCLA biologist Amander Clark, could help explain certain causes of infertility and spontaneous miscarriage.Infertility affects around 10 percent of the U.S. population, and roughly 15 to 20 percent of all pregnancies in the U.S. end in miscarriage. In many cases, the causes of infertility and miscarriage are unknown.A team led by Clark, a UCLA professor of molecular cell and developmental biology and member of the  Eli and Edythe Br...
Source: UCLA Newsroom: Health Sciences - April 25, 2018 Category: Universities & Medical Training Source Type: news

MRI helps distinguish fibroids from uterine cancer
T2-weighted MR images are effective for distinguishing between uterine fibroids...Read more on AuntMinnie.comRelated Reading: Fewer women are getting hysterectomies SIR: Women unaware of UFE as fibroid treatment option Study: UFE can help restore fertility SIR: UFE use still lags hysterectomy for fibroids Under scrutiny: Pregnancy after uterine fibroid embolization (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 25, 2018 Category: Radiology Source Type: news

TIME 100 ’s Giuliano Testa: We Should Think About Infertility As a ‘Wellbeing Issue’
Dr. Giuliano Testa, a transplant surgeon at Baylor University Medical Center at Dallas who led the medical team that performed the first successful uterus transplants in the United States, said Tuesday that he hopes “what we are doing is going to shed light on infertility for women.” “I personally never knew it was such a widespread issue,” Testa said at the TIME 100 Gala on Tuesday. “We should be thinking about it not just as a birth, but a wellbeing issue.” Testa attended the TIME 100 Gala after being named by TIME magazine as one of the most influential people in the world for his rol...
Source: TIME: Health - April 24, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized onetime T1002018 Source Type: news

New Drug Combo Ups Survival in HER2/neu Uterine Serous Cancer
WEDNESDAY, April 18, 2018 -- For patients with human epidermal growth factor receptor 2 (HER2)/neu-positive uterine serous carcinoma, adding intravenous trastuzumab to treatment with carboplatin-paclitaxel is associated with increased... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 18, 2018 Category: Pharmaceuticals Source Type: news

New drug combo improves survival of women with rare uterine cancer
(Johns Hopkins Medicine) Adding the monoclonal antibody drug trastuzumab -- already used to treat certain breast cancers -- to the chemotherapy regimen of women with a rare form of uterine cancer lengthens the amount of time their tumors are kept from growing, according to Johns Hopkins Medicine researchers conducting a small phase II trial of the regimen, testing its safety and value (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 10, 2018 Category: Cancer & Oncology Source Type: news

Embolx wins $2m NIH grant for pressure-directed embolization therapy
Embolx said today that it landed a $2 million grant from the National Cancer Institute to fund development of its next-generation Sniper balloon occlusion microcatheter. The Sunnyvale, Calif.-based medical device company has developed a drug-delivery system that administers therapies into targeted areas of the body by controlling pressure. Embolx’s Sniper balloon is designed to treat cancerous tumors, benign prostatic hyperplasia and uterine fibroids, according to the company. Get the full story at our sister site, Drug Delivery Business News. The post Embolx wins $2m NIH grant for pressure-directed emboliz...
Source: Mass Device - April 6, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Funding Roundup Pharmaceuticals Research & Development embolx National Institutes of Health (NIH) Source Type: news

Does Trastuzumab Plus Carbo/Paclitaxel Up PFS in Advanced HER2+ Uterine Carcinoma?
At SGO 2018, an early study showed ‘encouraging’ PFS with trastuzumab added to combination carboplatin/paclitaxel for advanced HER2/neu-overexpressing uterine serous carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - March 30, 2018 Category: Cancer & Oncology Authors: Bryant Furlow Tags: Gynecologic Cancers News Conferences/SGO Source Type: news

Symptoms of Uterine Cancer vs Fibroids
Symptoms of Uterine Cancer vs. Fibroids (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - March 23, 2018 Category: General Medicine Source Type: news

Eximis Surgical raises $5m for minimally-invasive tissue removal tool
Eximis Surgical raised $5.1 million as part of a $10.2 million equity round, according to a form filed with the SEC last week. Nearly 30 investors have contributed to the offering, the Colorado-based company reported. Eximis Surgical is developing a surgical tool called XCor, which is designed for minimally-invasive specimen removal in laparoscopic surgery. The company touted its technology as reducing surgery times and lessening the risks associated with traditional tissue removal methods, like morcellation. Power morcellators, used to shred and remove tissue, have been linked to the spread of cancerous cells th...
Source: Mass Device - March 5, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Funding Roundup Surgical Covidien eximissurgical Source Type: news

A Second Baby Has Been Born Via Uterus Transplant in the U.S.
A second woman in the U.S. born without a uterus has given birth to a baby, thanks to a uterus transplant. The birth took place at Baylor University Medical Center at Dallas, a part of Baylor Scott & White, which performed the first birth via uterus transplant late last year. The baby, born in February, is a girl. The hospital is not revealing the identity of the mother, but says the pregnancy and birth were uncomplicated. The birth is the second in the hospital’s ongoing uterus transplant clinical trial. The women in the trial have absolute uterine factor infertility (AUI), which means their uterus is nonfunctio...
Source: TIME: Health - March 4, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized fertility healthytime onetime Source Type: news

New guidelines for breast cancer survivors push "cheap hormone pills" with horrible side effects like nausea, vomiting and uterine cancer
(Natural News) New, insidious cancer care guidelines were put forth by The United Kingdom’s National Institute for Health Care Excellence (NICE). The guidelines instruct breast cancer survivors to take cheap hormone pills on a daily basis for up to ten years following chemotherapy (if the patient survives the chemotherapy). The current recommendations suggest a steady... (Source: NaturalNews.com)
Source: NaturalNews.com - January 31, 2018 Category: Consumer Health News Source Type: news